Catalent Inc (CTLT)

HEALTH CARE: HEALTH CARE SUPPLIES
SIC: PHARMACEUTICAL PREPARATIONS

14 SCHOOLHOUSE ROAD SOMERSET, NJ 08873

Catalent, Inc. provides delivery technologies and development solutions for drugs, biologics and consumer health products. The Company's oral, injectable, and respiratory delivery technologies address the diversity of the pharmaceutical industry including small molecules, large molecule biologics and consumer health products.

Data as of 2020-05-24
Market Cap12.163 Billion Shares Outstanding154.898 Million Avg 30-day Volume1.16 Million
P/E Ratio112.2 Dividend Yield EPS0.7
Price/Sales4.234 Price cash flow ratio32.9 Price free cash flow ratio-7.7
Book Value14.12 Price to Tangible Book-10.41 Alpha0.01
Short Interest Ratio3.77 % Short Interest to Float2.6 R-squared0.514263
BETA2.61667 52-week High/Low79.93 / 31.04 Stddev0.154957
View SEC Filings from CTLT instead.

View recent insider trading info

Funds Holding CTLT (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CTLT BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

LUCIER GREGORY T

  • Director
0 2020-05-28 3

GREISCH JOHN J

  • Director
20,250 2020-05-22 1

CLASSON ROLF A

  • Director
8,733 2020-05-15 1

CARROLL J MARTIN

  • Director
42,065 2020-05-13 3

MOREL DONALD E JR

  • Director
48,871 2020-05-13 1

WALSH MATTHEW M EVP, CHIEF FINANCIAL OFFICER

  • Officer
0 2020-05-08 0

CHU CHINH CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2020-04-23 0

GENNADIOS ARISTIPPOS PRESIDENT SOFTGEL & ORAL TECH

  • Officer
44,520 2020-04-09 5

FASMAN STEVEN L SVP & GENERAL COUNSEL

  • Officer
63,206 2020-04-09 5

JOSEPH WETTENY SVP & CHIEF FINANCIAL OFFICER

  • Officer
46,776 2020-04-09 4

MASELLI ALESSANDRO PRESIDENT & COO

  • Officer
13,117 2020-04-09 6

GUNTHER SCOTT SVP, QUALITY & REG. AFFAIRS

  • Officer
16,189 2020-04-09 4

ARNOLD JONATHAN PRES. ORAL & SPECIALTY DELIV.

  • Officer
34,509 2020-04-09 4

SCHMIDT KAY A SVP, TECHNICAL OPERATIONS

  • Officer
12,021 2020-04-09 5

BUZY PETER L PRESIDENT, GENE THERAPY

  • Officer
45,950 2020-04-09 2

PRAVDA RICARDO SVP & CHIEF HR OFFICER

  • Officer
11,072 2020-04-09 6

GRIPPO MICHAEL J SVP, STRATEGY & CORP. DEV.

  • Officer
16,282 2020-04-09 5

FLYNN KAREN PRES. BIOLOGICS & CCO

  • Officer
35,645 2020-04-09 3

WHITLOW RICCI S PRESIDENT, CSS

  • Officer
2,704 2020-04-09 3

QUELLA JAMES

  • Director
0 2020-03-31 0

BALACHANDRAN MADHAVAN

  • Director
8,068 2020-02-27 1

MCEVOY BRUCE

  • Director
0 2020-01-17 0

STAHL JACK L

  • Director
0 2019-12-19 1

CHIMINSKI JOHN R CHAIR & CEO

  • Officer
  • Director
214,607 2019-12-11 5

LITTLEJOHNS BARRY PRESIDENT, BIOLOGICS & SDD

  • Officer
45,882 2019-08-22 4

CRANE ROSEMARY A

  • Director
8,543 2019-08-22 1

KREUZBURG CHRISTA

  • Director
6,930 2019-08-22 1

HEGWOOD PAUL W JR PRESIDENT, CSS

  • Officer
11,848 2019-08-22 3

ZIPPELIUS PETER

  • Director
3,642 2019-08-22 1

MIYAMOTO LANCE SVP, HUMAN RESOURCES

  • Officer
46,799 2019-03-07 0

DOWNIE WILLIAM SVP, GLOBAL SALES & MARKETING

  • Officer
34,926 2019-02-15 0

ROEHRHOFF UWE CEO

  • Officer
  • Director
7,500 2018-03-08 0

BOOTH MELVIN D

  • Director
38,202 2018-03-01 0

DOLAN CHRISTINE SVP - PRODUCT DEVELOPMENT

  • Officer
19,449 2017-08-29 0

JOHNSON SHARON SEE REMARKS

  • Officer
30,829 2017-04-25 0

BLACKSTONE MANAGEMENT ASSOCIATES V L.L.C.

BLACKSTONE HEALTHCARE PARTNERS L.L.C.

BLACKSTONE CAPITAL PARTNERS V L P

BMA V L.L.C.

BLACKSTONE HOLDINGS III L.P.

BLACKSTONE HOLDINGS III GP L.P.

BLACKSTONE HOLDINGS III GP MANAGEMENT L.L.C.

BLACKSTONE GROUP L.P.

BLACKSTONE GROUP MANAGEMENT L.L.C.

SCHWARZMAN STEPHEN A

  • 10% Owner
No longer subject to file 2016-09-09 0

LEONARD STEPHEN SEE REMARKS

  • Officer
51,741 2016-07-26 0

HOULTON SCOTT SEE REMARKS

  • Officer
0 2015-09-02 0

BLACKSTONE HEALTHCARE PARTNERS L.L.C.

  • 10% Owner
40,030,960 2015-04-14 0

KURT NIELSEN SEE REMARKS

  • Officer
23,676 2015-02-17 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

CARROLL J MARTIN - Director by spouse

2020-05-12 J 3,600 $72.29 d 0 23,849.00 indirect

CARROLL J MARTIN - Director by spouse

2020-05-12 G 3,600 a 3,600 23,849.00 indirect

CARROLL J MARTIN - Director by trust

2020-05-12 J 3,600 $72.29 a 8,527 23,849.00 indirect

CARROLL J MARTIN - Director

2020-05-12 G 3,600 d 15,322 23,849.00 direct

BUZY PETER L - Officer PRESIDENT, GENE THERAPY

2020-04-09 A 266 $56.46 a 45,950 45,950.00 direct

FASMAN STEVEN L - Officer SVP & GENERAL COUNSEL

2020-04-09 A 386 $56.46 a 63,206 63,206.00 direct

GRIPPO MICHAEL J - Officer SVP, STRATEGY & CORP. DEV.

2020-04-09 A 256 $56.46 a 16,282 16,282.00 direct

MASELLI ALESSANDRO - Officer PRESIDENT & COO

2020-04-09 A 315 $56.46 a 13,117 13,117.00 direct

WHITLOW RICCI S - Officer PRESIDENT, CSS

2020-04-09 A 240 $56.46 a 2,704 2,704.00 direct

FLYNN KAREN - Officer PRES. BIOLOGICS & CCO

2020-04-09 A 359 $56.46 a 35,645 35,645.00 direct

GUNTHER SCOTT - Officer SVP, QUALITY & REG. AFFAIRS

2020-04-09 A 243 $56.46 a 16,189 16,189.00 direct

PRAVDA RICARDO - Officer SVP & CHIEF HR OFFICER

2020-04-09 A 226 $56.46 a 11,072 11,072.00 direct

ARNOLD JONATHAN - Officer PRES. ORAL & SPECIALTY DELIV.

2020-04-09 A 264 $56.46 a 34,509 34,509.00 direct

GENNADIOS ARISTIPPOS - Officer PRESIDENT SOFTGEL & ORAL TECH

2020-04-09 A 279 $56.46 a 44,520 44,520.00 direct

JOSEPH WETTENY - Officer SVP & CHIEF FINANCIAL OFFICER

2020-04-09 A 349 $56.46 a 46,776 46,776.00 direct

SCHMIDT KAY A - Officer SVP, TECHNICAL OPERATIONS

2020-04-09 A 226 $56.46 a 12,021 12,021.00 direct

Elevate your investments